-
DiscoveryDNA-encoded molecules provide a new edge in cancer drug hunts
Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.
Discovery -
DiscoveryBuilding “boot camps” for immune cells near tumors
Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
Discovery -
DiscoveryTaking on obesity
Novartis is developing an experimental drug for weight loss.
Discovery -
DiscoveryPotential weight loss treatment takes shape with help from patients
Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.
Discovery -
DiscoveryCompound designed to fight Alzheimer’s disease shows promise in the lab
The molecule restores the activity of neurons and neural circuits in a model of the disease.
Discovery -
DiscoveryTracking patients’ progress with radio signals and machine learning
Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.
Discovery -
DiscoveryOrganic dealmaker for drug discovery
New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
Discovery -
DiscoveryOpen science demystified
Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.
Discovery -
DiscoveryResearchers overcome hurdles to test experimental malaria drug
The race is on to find a new treatment before resistance to today’s drugs becomes widespread.
Discovery -
DiscoverySmall viruses could accelerate cell and gene therapy research
Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.
Discovery -
DiscoveryExploring longstanding questions about heart disease
New Global Head of Cardiovascular and Metabolic Diseases Research looks to apply new tools to address tough challenges.
Discovery -
DiscoveryEye on patients, mind on innovation
New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.
Discovery